Open Access

Erratum to: In vitro and in vivo activity of miR-92a–Locked Nucleic Acid (LNA)–Inhibitor against endometrial cancer

  • Anna Torres1Email author,
  • Joanna Kozak1,
  • Agnieszka Korolczuk2,
  • Paulina Wdowiak1,
  • Ewa Domańska-Glonek1,
  • Ryszard Maciejewski3 and
  • Kamil Torres3
BMC Cancer201616:939

https://doi.org/10.1186/s12885-016-2971-0

Received: 23 November 2016

Accepted: 23 November 2016

Published: 7 December 2016

The original article was published in BMC Cancer 2016 16:822

Erratum

After the publication of the article [1], the authors realised it contained an error with the Methods section. The following paragraph should be deleted from the original article:

Cell proliferation assay

Proliferation was measured using Delfia cell proliferation kit (Perkin-Elmer, Waltham, MA, USA) according to manufacturer protocol. BrdU incorporation was measured by time–resolved fluorescence 48 h after transfection using VictorX4 multimode plate reader (Perkin-Elmer, Waltham, MA, USA). All experiments were performed in triplicates and repeated tree times.

Please note that the original article was corrected.

Notes

Declarations

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

(1)
Laboratory of Biostructure, Chair of Human Anatomy, Medical University of Lublin
(2)
Department of Clinical Pathomorphology, Medical University of Lublin
(3)
Chair of Human Anatomy, Medical University of Lublin

Reference

  1. Torres A, et al. In vitro and in vivo activity of miR-92a–Locked Nucleic Acid (LNA)–Inhibitor against endometrial cancer. BMC Cancer. 2016;16:822. doi:https://doi.org/10.1186/s12885-016-2867-z.View ArticlePubMedPubMed CentralGoogle Scholar

Copyright

© The Author(s). 2016

Advertisement